Altria: It's Time To Return To This High Dividend Yield Opportunity (Rating Upgrade)
Altria Group stock outperformed the S&P 500 over the past year (total return), something you don't hear about so often. See ...
FDA Wants to Curb Nicotine in Cigarettes, But Plan’s Fate Rests With Trump
Officials proposed limiting the amount of nicotine to make cigarettes less addictive, but it's unclear if the incoming ...
Altria: A High-Yielding Dividend Gem To Buy Now
Discover why Altria may be a strong investment opportunity, with potential for significant total returns and a possible ...
STAT2d
FDA authorizes sale of Zyn nicotine pouches, saying public health benefits outweigh risk
Zyn and the retailers who sell the product have run afoul of regulators in recent years. The FDA in April of last year warned ...
US regulators propose capping nicotine in cigarettes at non-addictive levels
U.S. regulators are proposing to cap the amount of nicotine in cigarettes at non-addictive levels, in a potential world-first ...
FDA approves Zyn nicotine pouches, citing health benefits for adult smokers
Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris ...
Morgan Stanley Begins Coverage on Altria Group (NYSE:MO)
Morgan Stanley began coverage on shares of Altria Group (NYSE:MO – Free Report) in a research note issued to investors on Thursday morning, Marketbeat Ratings reports. The brokerage issued an equal ...
Altria Group Faces Market Pressure Amid Shifting Consumer Preferences and Increased Competition
In a report released today, Eric Serotta from Morgan Stanley maintained a Hold rating on Altria Group (MO – Research Report), with a price ...
kcra.com3d
FDA releases proposal to cap nicotine in cigarettes
Even if the effort goes ahead under Trump, tobacco companies like Reynolds American and Altria are almost certain to challenge it in court, delaying implementation. The FDA has spent years ...